Abstract Submission :

Submit Abstract

Registration :

Register Now

Become a Sponsor/Exhibitor :

Become a Sponsor

Conference Organizing Committee :

View Committee

Register Now :

Register Now

Conference Program :

Brochure Download

SCIENTIFIC SESSIONS

  • Alzheimer's disease
  • Parkinson's disease
  • Dementia
  • Schizophrenia
  • Animal Models in Dementia
Read More

IMPORTANT DATES

Abstract Submission
August 01, 2019

Early Bird Registration
March 30, 2019

Register Now

About Conference


We are pleased to welcome the scientific fraternity across the world to join Global Alzheimer’s and Dementia Conference to be held during July 16-18, 2020 at Paris, France.

Our scientific program, presented over the course of three days will have the productive sessions of keynote presentations, oral sessions, young research forum, symposia, poster presentation, workshops, exhibitions, roundtables and variable formats. This conference gathers Doctors, Scientists, Professors, and other Medical and Clinical Researchers both from academic and business organizations globally.

Join us to redefine and explore new research, to provide a credible source to barter ideas for scientific studies besides transforming the true outcomes of a distinct scientific discovery and grab the attention for rare emerging technologies.

Importance and Scope

Global Alzheimer’s and Dementia Conference aims to showcase the scientific developments that are already resulting in measurable benefits for patients suffering with Alzheimers and Dementia. Our conference is based on the theme “Changing the perception and enhancing new strategies to fight Dementia”.

Conference Objectives

  • To facilitate opportunities for networking, collaboration and exchange of ideas with internationally renowned researchers fighting against Alzheimers and Dementia.
  • To identify research and practice based innovations in optimizing diagnosis for Alzheimer.
  • To debate gaps and priorities for sustainable development and solutions to fight Dementia research.

Why to attend?

Dementia and Alzheimers research has provided a deeper understanding of how much Alzheimer’s affects the brain, in the last three decades. Today, Scientists and researchers across the world are continuing to look for more effective treatments and cure, to prevent Alzheimer’s and improve brain health. So, Global Alzheimer’s and Dementia Conference provides a platform to the researchers to distribute information, conduct presentations and meet with current and potential scientists across the globe who are working mutually towards Dementia Research.  Make a splash with new researches and its developments in this 2-day event at Dementia and Alzheimers 2018 conference. World-renowned speakers, recent techniques, developments and newest updates in Dementia research and treatment are major parts of this conference.

Young Researchers Opportunity

  • Establishing their academic and professional relationships.
  • Improving their morale and confidence of presenting research in an international platform.
  • Interacting with expertise in their respective departments.
  • Clearing your inhibitions of adjusting to the foreign environment.
  • Providing a holistic experience of academic tourism.

Target Audience

  • Academicians
  • Medical Colleges
  • Research faculty
  • Students
  • Oncologists
  • Pathologists
  • Cancer & Oncology Societies Professionals
  • Diagnostic laboratory professionals          
  • Presidents & Vice Presidents
  • Directors/Managers/CEO’s
  • Bio-Medical Company professionals
  • Industry Professionals
  • Corporate Cancer Research Professional
  • Pharmacists Business Entrepreneurs
  • Medical Devices Companies
  • Biotechnology Companies
  • Marketing, Advertising and Promotion Agency Executives.

Scientific Session


Alzheimer's disease

Alzheimer's is a type of dementia that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe enough to interfere with daily tasks. Alzheimer's disease accounts for 60 to 80 percent of dementia cases.

 

Parkinson's disease

Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms continue and worsen over time. Nearly one million people in the US are living with Parkinson's disease. The cause is unknown, and although there is presently no cure, there are treatment options such as medication and surgery to manage its symptoms.

 

Dementia

Dementia is a general term for loss of memory and other mental abilities severe enough to interfere with daily life. It is caused by physical changes in the brain. Alzheimer's disease is the most common cause of a progressive dementia in older adults, but there are a number of causes of dementia. Depending on the cause, some dementia symptoms can be reversed.

Dementia symptoms vary depending on the cause, but common signs and symptoms include Memory loss, cognitive changes, Psychological changes, Difficulty with coordination and motor functions

 

Schizophrenia

Schizophrenia is a chronic and severe mental disorder that affects how a person thinks, feels, and behaves. People with schizophrenia may seem like they have lost touch with reality. Although schizophrenia is not as common as other mental disorders, the symptoms can be very disabling.

Because the causes of schizophrenia are still unknown, treatments focus on eliminating the symptoms of the disease. Some of the common symptoms are Hallucinations, Movement disorders (agitated body movements), Reduced speaking

 

Vascular Dementia

Vascular dementia is a decline in thinking skills caused by cerebrovascular disease, a condition in which blood vessels in the brain are damaged and brain tissue injured, depriving brain cells of vital oxygen and nutrients. Vascular dementia symptoms vary, depending on the part of your brain where blood flow is impaired. Symptoms often overlap with those of other types of dementia, especially Alzheimer's disease dementia. Vascular dementia symptoms may be most clear-cut when they occur suddenly following a stroke. When changes in your thinking and reasoning seem clearly linked to a stroke, this condition is sometimes called post-stroke dementia. Sometimes a characteristic pattern of vascular dementia symptoms follows a series of strokes or ministrokes. Changes in your thought processes occur in noticeable steps downward from your previous level of function, unlike the gradual, steady decline that typically occurs in Alzheimer's disease dementia.

 

Animal Models in Dementia

Many clinical studies focus on finding better ways to accurately diagnose Alzheimer's disease, particularly in the early stages. These studies will hopefully lead to a trusted and easy-to-apply method that enables physicians to diagnose persons at risk for the disease even before symptoms appear and begin treatment. Diagnostic studies are vital to the advancement of Alzheimer's research because they identify which individuals to treat and provide doctors with a way to track whether a treatment is working. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signaling, neuroinflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and ongoing promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.

 

Drug Development in Dementia

Many clinical studies focus on finding better ways to accurately diagnose Alzheimer's disease, particularly in the early stages. These studies will hopefully lead to a trusted and easy-to-apply method that enables physicians to diagnose persons at risk for the disease even before symptoms appear and begin treatment. Diagnostic studies are vital to the advancement of Alzheimer's research because they identify which individuals to treat and provide doctors with a way to track whether a treatment is working. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signaling, neuroinflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and ongoing promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.

 

Neurodegenerative Diseases

Neurodegenerative diseases affect millions of people worldwide, and Alzheimer’s disease and Parkinson’s disease are the most common types. More than five million Americans are living with Alzheimer’s disease, and at least 500,000 Americans live with Parkinson's disease, although some estimates are much higher. Neurodegenerative diseases occur when nerve cells in the brain or peripheral nervous system lose function over time and ultimately die. Although treatments may help relieve some of the physical or mental symptoms associated with neurodegenerative diseases, there is currently no cure or way to slow disease progression. The risk of being affected by a neurodegenerative disease increases dramatically with age. Population-wide health improvements have increased lifespan, which along with a larger generation of aging Americans means more people may be affected by neurodegenerative diseases in coming decades. This creates a critical need to improve our understanding of what causes neurodegenerative diseases and develop new approaches for treatment and prevention.

 

Central Nervous System

The Central nervous system is the part of the nervous system consisting of the brain and spinal cord. It is referred as central because it combines information from the entire body and coordinated activity over the whole organism. CNS disorders can affect either the brain or the spinal cord which conclusion in psychiatric disorders or neurological disorders. The causes of CNS diseases are the neurology, trauma, autoimmune disorders, infections, structural defects, degeneration and tumours. So here we target on mood disorders, neurodegenerative diseases, schizophrenia and autism. Meningitis is an almost rare infection that affects the delicate membranes called meninges that cover the brain and spinal cord. By infection or allergic reactions, inflammation of brain occurs, it is known as Encephalitis.

 

Spine and Spinal Disorders

Spine disorders occur in individuals irrespective of their age -spina bifida in infants to spinal stenosis in the elderly. Causes of spinal cord disorders include mainly injuries, infections, blocked blood supply, and compression by a fractured bone or a tumor. The boost in spinal disorders has been met with a leap in advancements in the diagnostic techniques. Endoscopic spine, MRI, X- rays CT and DEA are some of the generally used tools in diagnosing spinal disorders.

 

Neuroimmunology and Neuroinfections

Neuroimmunology a branch of immunology that deals especially with the interrelationships of the nervous system and immune responses and autoimmune disorders. Its deals with particularly fundamental and applied neurobiology, neurology, neuropathology, neurochemistry, neurovirology, neuroendocrinology, neuromuscular research, neuropharmacology and psychology, which involve either immunologic methodology (e.g. immunocytochemistry) or fundamental immunology (e.g. antibody and lymphocyte assays).

 

Brain Tumor and Neuro-Oncology

The abnormal cell growth and sudden reactions taking place from central nervous system results in brain tumour. Neuro-oncology is the study of brain and spinal cord neoplasms, which are very dangerous and life-threatening. Astrocytoma, glioblastoma, glioma, multiforme, ependymoma, pontine glioma, and brain stem tumours are some of the examples. Surgery may in some cases be the medicinal but malignant brain cancers turn to regenerate and emerge from absolution easily, especially highly malignant cases.

 

Neuro Cardiology & Strokes

Neurocardiology is the study of neurophysiological, neurological and neuroanatomical aspects of cardiology especially including the neurological origins of cardiac disorders. It also refers to the pathophysiological interplays of the nervous and cardiovascular systems.  The effects of stress on the heart are studied in terms of the heart's interactions with the two peripheral nervous system and central nervous system. Scientific issues in neurocardiology include hypoxic-ischemic brain injury, neurogenic stress cardiomyopathy, cerebral embolism and encephalopathy, neurologic sequelae of cardiac and thoracic surgery, cardiac interventions, and cardiovascular findings in patients with primary neurological disease.

A stroke is a "brain attack". It can appear to anyone at any time when poor blood flow to an area of brain and results in cell death. When this happens brain cells are dispossessed of oxygen and begin to die. When brain cells die during a stroke it controls ability by that area of the brain such as memory and muscle control is lost.

 

Depression and Anxiety Disorders

Depression and anxiety disorders are different, but people with depression often experience symptoms similar to those of an anxiety disorder, such as nervousness, irritability, and problems sleeping and concentrating. But each disorder has its own causes and its own emotional and behavioral symptoms. There are different types of depressive disorders, and while there are many similarities among them, each depressive disorder has its own unique set of symptoms. A person may lose interest in work, hobbies and doing things he or she normally enjoys. Some people may lack energy, have difficulty sleeping or sleep more than usual, while some people feel anxious or irritable and find it hard to concentrate.

 

Dementia risk factors

New research suggests high blood pressure during mid-life led to increased risk of Alzheimer's in later life. Repeated blows to the head may have more of an impact on dementia risk than concussion, studies on war veterans and American footballers previously revealed. Psychological stress and obesity during mid-life were other factors thought to increase risk of dementia. Researchers also highlighted the importance of exercise. New studies suggest regular exercise even in people experiencing stress can reduce risk. Interestingly exercise seems to have greater benefits for working memory, such as multitasking skills, in women than men.

 

Diagnosis, Prevention and treatment of dementia

Diagnosing dementia and determining what type it is can be challenging. A diagnosis of dementia requires that at least two core mental functions be impaired enough to interfere with daily living. They are memory, language skills, ability to focus and pay attention, ability to reason, solve problem and visual perception. No single test can diagnose dementia, so doctors are likely to run a number of tests that can help pinpoint the problem. Some of the tests include Cognitive and neuropsychological tests, Brain scans and Psychiatric evaluation. Transcranial magnetic stimulation used to, carefully and non-invasively, stimulate certain areas of the brain showed a reduction in apathy for people with dementia. Researchers have used light therapy to treat sleep disturbances in dementia improving the quality of life of both those affected and their carers.

Scientific Sessions

Abstract Submission : August 01, 2019

Early Bird Registration : March 30, 2019

  • Alzheimer's disease
  • Parkinson's disease
  • Dementia
  • Schizophrenia
  • Animal Models in Dementia
  • Drug Development in Dementia
  • Neurodegenerative Diseases
  • Depression and anxiety disorders
  • Epilepsy
  • Migraine
  • Motor Neurone diseases
  • Neurodegenertaion
  • CNS Disorders

Registration Categories

Abstract Submission : August 01, 2019

Early Bird Registration : March 30, 2019

Awards

GADC (Global Alzheimer’s & Dementia Conference) anticipates being able to provide funding to assist some attendees coming from Lower and Middle Income Countries to present their science at the summit.  Participants desiring to be considered for one of these awards need to specify their interest after their submission of the required abstract. Selected participants will receive a sum of $250 to $1,000 (USD) scholarship under the 3 categories.

1.     Outstanding Submitted Abstract of the GADC.

2.     Best Research of the conference as evaluated by the Scientific Committee.

3.     Young Researcher Award under YRF category to encourage budding scientists/ researcher.

Decisions will be made based on evaluation of the submitted abstract by the scientific committee and amount of funds available.

We want you to grab this opportunity and participate in the conference.

Need Help ? Write to Us